08 June 2020

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

08 June 2020 | n=38

  1. Coleman H, Snell LB, Simons R, Douthwaite ST, et al.
    Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
    AIDS 2020;34:1258-1260.

  2. Di Giambenedetto S, Del Giacomo P, Ciccullo A, Porfidia A, et al.
    SARS-CoV-2 infection in a highly experienced person living with HIV.
    AIDS 2020;34:1257-1258.

  3. Dauby N.
    Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
    AIDS 2020;34:1255-1256.

  4. Cattaneo D, Minisci D, Formenti T, Negri C, et al.
    The prescribing cascade 3.0: a case for recreational drugs in HIV.
    AIDS 2020;34:1253-1255.

  5. Brenner BG.
    Phylogenetics: an added ingredient in HIV prevention.
    AIDS 2020;34:1247-1248.

  6. Nguyen N, Choi CJ, Robbins R, Korich R, et al.
    Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.
    AIDS 2020;34:1205-1215.

  7. Ye L, Wang J, Teque F, Xie F, et al.
    Generation of HIV-1-infected patients' gene-edited induced pluripotent stem cells using feeder-free culture conditions.
    AIDS 2020;34:1127-1139.

  8. Odhiambo F, Mulwa E, Ayieko J, Kulzer J, et al.
    Implementation of HIV care in Western Kenya during corona virus disease 2019 response.
    AIDS 2020;34:F1-F2.

  9. van Halsema CL, Okhai H, Hill T, Sabin CA, et al.
    Incidence and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the UK.
    AIDS 2020.

  10. Ziegler MC, Nelde A, Weber JK, Schreitmuller CM, et al.
    HIV-1-induced changes in HLA-C*03: 04-presented peptide repertoires lead to reduced engagement of inhibitory NK cell receptors.
    AIDS 2020.

  11. Saulle I, Ibba SV, Vittori C, Fenizia C, et al.
    Sterol metabolism modulates susceptibility to HIV-1 Infection.
    AIDS 2020.

  12. Kabami J, Balzer LB, Saddiki H, Ayieko J, et al.
    Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
    AIDS 2020.

  13. Dekkers BGJ, Bierman WFW, Touw DJ, Alffenaar JC, et al.
    Relevance of the drug-drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat.
    AIDS 2019;33:1100-1102.

  14. Jacobs TG, Burger DM, Pranger AD, Khoo SH, et al.
    Carbamazepine intervention in a patient with efavirenz-induced liver injury.
    AIDS 2019;33:1097-1098.

  15. Cohen K, Viljoen C, Njuguna C, Maartens G, et al.
    Emtricitabine-associated red cell aplasia.
    AIDS 2019;33:1095-1096.

  16. Boyd SD, Sampson MR, Viswanathan P, Struble KA, et al.
    Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.
    AIDS 2019;33:1089-1093.

  17. Zhao J, Chen Q, Fu C, Qin Q, et al.
    Rate of the HIV transmission and associated factors among HIV-exposed infants in Guangxi , China: 2014-2019.
    AIDS Res Hum Retroviruses 2020.

  18. Gonese E, Musuka G, Ruangtragool L, Hakim A, et al.
    Comparison Of HIV Incidence In The Zimbabwe Population-Based HIV Impact Assessment Survey (2015-2016), With Modeled Estimates: Progress Toward Epidemic Control.
    AIDS Res Hum Retroviruses 2020.

  19. Segujja F, Omooja J, Lunkuse S, Nanyonjo M, et al.
    High levels of acquired HIV drug resistance following virological non-suppression in HIV-infected women from a high-risk cohort in Uganda.
    AIDS Res Hum Retroviruses 2020.

  20. Dhummakupt A, Persaud D.
    Capitalizing on Post-exposure ARV Prophylaxis to Restrict Seeding of the HIV Reservoir.
    Clin Infect Dis 2020.

  21. Karat AS, Gregg M, Barton HE, Calderon M, et al.
    Evidence for the use of triage, respiratory isolation, and effective treatment to reduce the transmission of Mycobacterium tuberculosis in health care settings: a systematic review.
    Clin Infect Dis 2020.

  22. Hojilla JC, Marcus JL, Silverberg MJ, Hare CB, et al.
    Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco.
    Clin Infect Dis 2020.

  23. Nachega JB, Grimwood A, Mahomed H, Fatti G, et al.
    From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis 2020.

  24. Shalev N, Scherer M, LaSota ED, Antoniou P, et al.
    Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.
    Clin Infect Dis 2020.

  25. Indravudh PP, Hensen B, Nzawa R, Chilongosi R, et al.
    Who is reached by HIV self-testing? Individual factors associated with self-testing within a community-based programme in rural Malawi.
    J Acquir Immune Defic Syndr 2020.

  26. Okoh AK, Bishburg E, Grinberg S, Nagarakanti S, et al.
    COVID-19 pneumonia in patients with HIV - A Case Series.
    J Acquir Immune Defic Syndr 2020.

  27. Naggie S, Lusk S, Thompson JW, Mock M, et al.
    Metabolomic signature as a predictor of liver disease events in patients with HIV/HCV co-infection.
    J Infect Dis 2020.

  28. Falcinelli SD, Shook-Sa BE, Dewey MG, Sridhar S, et al.
    Impact of biological sex on immune activation and frequency of the latent HIV reservoir during suppressive antiretroviral therapy.
    J Infect Dis 2020.

  29. Jilg N, Garcia-Broncano P, Peluso M, Segal FP, et al.
    Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art.
    J Infect Dis 2020.

  30. Smith JA, Garnett GP, Hallett TB.
    The potential impact of long-acting cabotegravir for HIV prevention in South Africa: a mathematical modelling study.
    J Infect Dis 2020.

  31. Novitsky V, Zahralban-Steele M, Moyo S, Nkhisang T, et al.
    Mapping of HIV-1C Transmission Networks Reveals Extensive Spread of Viral Lineages across Villages in Botswana Treatment-as-Prevention Trial.
    J Infect Dis 2020.

  32. Adadi P, Kanwugu ON.
    Living with HIV in the time of COVID-19: a glimpse of hope.
    J Med Virol 2020.

  33. Tagnouokam-Ngoupo PA, Toby R, Ebede MOB, Kenmoe S, et al.
    Detection of Herpesviruses and Enteroviruses in Patients with Suspected Infectious Meningoencephalitis in Three Referral Hospitals in Yaounde, Cameroon.
    J Med Virol 2020.

  34. Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, et al.
    A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
    J Med Virol 2020.

  35. Beitari S, Pan Q, Finzi A, Liang C, et al.
    Differential pressures of SERINC5 and IFITM3 on HIV-1 envelope glycoprotein over the course of HIV-1 infection.
    J Virol 2020.

  36. Puras D, de Mesquita JB, Cabal L, Maleche A, et al.
    The right to health must guide responses to COVID-19.
    Lancet 2020.

  37. Diack A, Yonaba C, Coulibaly A, Ouedraogo S, et al.
    Progressive Decline of the Glomerular Filtration Rate in HIV-infected Children Treated With Tenofovir Disoproxil Fumarate-based Regimens in West and Central Africa.
    Pediatr Infect Dis J 2020.

  38. Sartoris G, Seddon JA, Rabie H, Nel ED, et al.
    Abdominal Involvement in Children With Bacteriologically Confirmed Tuberculosis: A Five-year Experience From Cape Town, South Africa.
    Pediatr Infect Dis J 2020.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

13 July 2020

06 July 2020

29 June 2020

22 June 2020

15 June 2020

08 June 2020

Multidisciplinary Journal Club

  1. Chiarito M, Sanz-Sanchez J, Cannata F, Cao D, et al.
    Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.
    Lancet. 2020;395:1487-1495.

  2. Ju B, Zhang Q, Ge J, Wang R, et al.
    Human neutralizing antibodies elicited by SARS-CoV-2 infection.
    Nature. 2020 May 26. pii: 10.1038/s41586-020-2380.

  3. Sternberg CN, Fizazi K, Saad F, Shore ND, et al.
    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med. 2020 May 29. doi: 10.1056/NEJMoa2003892.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016